Design, synthesis and evaluation of potential glycoside hydrolase inhibitors based on castanospermine and swainsonine. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Design, synthesis and evaluation of potential glycoside hydrolase inhibitors based on castanospermine and swainsonine.

Diss Abstr Int [B]; 55(3):1051 1994. Unique Identifier : AIDSLINE ICDB/95607537
Tan P; State Univ. of New York at Buffalo


Abstract: A family of new analogues of polyhydroxylated indolizidine alkaloids swainsonine and castanospermine was synthesized and evaluated as potential inhibitors of alpha-mannosidase or alpha-glucosidase, the enzymes required in the secondary processing of glycoprotein biosynthesis in HIV virus and tumor cells. N-swainsonine [(1S,2R,8R,8aR)-1,2,8-trihydroxy-1,2,3,7,8,8a-hexahydropyrrolo-(1- ,2-c)pyrimidine], an amidine analogue of swainsonine synthesized in 12 steps from stereochemically defined D-mannose via a hydrogenolysis-reductive-amination key step, was a specific, time-dependent inhibitor of jack bean alpha-mannosidase with a Ki of 5.2 mM, a k(inact) of 0.20/min and half-life (t1/2) of 3.5 min. Swainsonine and N-swainsonine showed cooperative inhibition, the presence of the known competitive inhibitor swainsonine (1.0 uM) in the assay media enhanced the binding of N-swainsonine to alpha-mannosidase 29-fold (Ki = 0.18 mM) in accordance with the proposed kinetic model, which suggests that swainsonine and N-swainsonine bind to different sites of alpha-mannosidase. A binding model for enzyme-inhibitor interaction and the possible covalent modification of alpha-mannosidase by N-swainsonine were proposed. All the other 5-substituted N-swainsonines (5-methyl-, 5-amino-, 5-alkylamino-N-swainsonine, N-swainsonine-5-one and 5-thione) did not show any activity against both jack bean alpha-mannosidase or baker's yeast alpha-glucosidase. O-swainsonine [(1S,2R,8S,8aR)-1,2,8-trihydroxy-2H (1,2,3,7,8,8a)hexahydro-pyrrolo(1,2-c)(1,3)oxazine], which incorporated an oxygen atom into the 6-position of swainsonine, was equally as active as swainsonine against alpha-mannosidase. 6-Amino-1,4,6-trideoxy-1,4-imino-D-mannitol, an analogue of the known inhibitor DIM, was 22-fold less potent than swainsonine. The 2-substituted (2-alpha- and 2-beta-aminomethyl, 2-alpha- and 2-beta-cyano)3-alpha,4-beta-dihydroxy-1,2,3,4-tetrahydroquinoline derivatives, which possess the basic structural feature of castanospermine and were synthesized from the Reissert compounds, were found no activity against these two enzymes. (Full text available from University Microfilms International, Ann Arbor, MI, as Order No. AAD94-20218)
Keywords: alpha-Glucosidases/METABOLISM HIV/METABOLISM Indolizines/*METABOLISM Mannosidases/*METABOLISM Neoplasms/*METABOLISM Swainsonine/*METABOLISM THESISKWDalpha-glucosidases/metabolismhiv/metabolismindolizines/KWDmetabolismmannosidases/KWDmetabolismneoplasms/KWDmetabolismswainsonine/KWDmetabolismthesis
950830
M9581002

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .